Profile | GDS4284 / 244667_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 268.089 | 55 |
GSM687648 | Patient 402 control | 386.334 | 60 |
GSM687653 | Patient 403 control | 341.732 | 59 |
GSM687658 | Patient 404 control | 302.887 | 56 |
GSM687663 | Patient 411 control | 216.665 | 49 |
GSM687668 | Patient 422 control | 258.245 | 53 |
GSM687673 | Patient 424 control | 208.125 | 48 |
GSM687678 | Patient 425 control | 91.9956 | 31 |
GSM687683 | Patient 427 control | 165.787 | 42 |
GSM687688 | Patient 428 control | 48.7099 | 23 |
GSM687695 | Patient 441 control | 795.558 | 71 |
GSM687699 | Patient 443 control | 697.347 | 68 |
GSM687704 | Patient 444 control | 372.243 | 59 |
GSM687707 | Patient 448 control | 296.163 | 53 |
GSM687712 | Patient 449 control | 173.638 | 45 |
GSM687719 | Patient 450 control | 409.414 | 59 |
GSM687724 | Patient 451 control | 52.8094 | 22 |
GSM687728 | Patient 452 control | 210.362 | 48 |
GSM687646 | Patient 401 treated 24h | 265.991 | 53 |
GSM687649 | Patient 402 treated 24h | 81.6018 | 33 |
GSM687665 | Patient 411 treated 24h | 265.729 | 52 |
GSM687651 | Patient 402 treated 4 weeks | 248.363 | 51 |
GSM687667 | Patient 411 treated 4 weeks | 218.01 | 49 |
GSM687670 | Patient 422 treated 24h | 143.021 | 40 |
GSM687671 | Patient 422 treated 4 weeks | 215.435 | 50 |
GSM687654 | Patient 403 treated 24h | 211.136 | 51 |
GSM687675 | Patient 424 treated 24h | 286.309 | 53 |
GSM687685 | Patient 427 treated 24h | 100.653 | 34 |
GSM687656 | Patient 403 treated 4 weeks | 220.668 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 305.236 | 56 |
GSM687687 | Patient 427 treated 4 weeks | 283.54 | 55 |
GSM687692 | Patient 428 treated 4h | 250.107 | 52 |
GSM687716 | Patient 449 treated 4h | 174.466 | 46 |
GSM687722 | Patient 450 treated 4h | 130.635 | 36 |
GSM687680 | Patient 425 treated 24h | 313.68 | 56 |
GSM687690 | Patient 428 treated 24h | 147.988 | 43 |
GSM687700 | Patient 443 treated 24h | 720.743 | 67 |
GSM687705 | Patient 444 treated 24h | 197.277 | 50 |
GSM687714 | Patient 449 treated 24h | 41.3155 | 22 |
GSM687721 | Patient 450 treated 24h | 397.042 | 58 |
GSM687682 | Patient 425 treated 4 weeks | 189.15 | 48 |
GSM687694 | Patient 428 treated 4 weeks | 249.532 | 53 |
GSM687702 | Patient 443 treated 4 weeks | 631.908 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 45.158 | 21 |
GSM687723 | Patient 450 treated 4 weeks | 228.48 | 50 |
GSM687661 | Patient 404 treated 4h | 322.514 | 56 |
GSM687710 | Patient 448 treated 4h | 254.043 | 53 |
GSM687726 | Patient 451 treated 4h | 274.22 | 52 |
GSM687730 | Patient 452 treated 4h | 388.616 | 48 |
GSM687660 | Patient 404 treated 24h | 92.0245 | 28 |
GSM687697 | Patient 441 treated 24h | 229.842 | 45 |
GSM687709 | Patient 448 treated 24h | 207.944 | 47 |
GSM687725 | Patient 451 treated 24h | 301.935 | 53 |
GSM687729 | Patient 452 treated 24h | 443.708 | 61 |
GSM687727 | Patient 451 treated 4 weeks | 159.574 | 40 |
GSM687731 | Patient 452 treated 4 weeks | 389.26 | 59 |